1. Home
  2. EYE vs IMNM Comparison

EYE vs IMNM Comparison

Compare EYE & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$28.69

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.36

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYE
IMNM
Founded
1990
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
EYE
IMNM
Price
$28.69
$19.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
9
Target Price
$27.11
$26.89
AVG Volume (30 Days)
1.6M
1.2M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,921,355,000.00
$9,679,000.00
Revenue This Year
$9.80
N/A
Revenue Next Year
$4.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.33
N/A
52 Week Low
$9.93
$5.15
52 Week High
$29.87
$20.80

Technical Indicators

Market Signals
Indicator
EYE
IMNM
Relative Strength Index (RSI) 57.73 58.69
Support Level $27.63 $18.87
Resistance Level $29.87 $20.80
Average True Range (ATR) 1.21 1.22
MACD 0.11 -0.02
Stochastic Oscillator 66.62 70.80

Price Performance

Historical Comparison
EYE
IMNM

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: